| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 74849-93-7 | Cefpiramide Sodium |
≥98% | | 询价 |
| 2 | 1246819-17-9 | Nitazoxanide D4 |
≥98% | | 询价 |
| 3 | 173903-47-4 | Tizoxanide |
≥98% | | 询价 |
| 4 | 64953-12-4 | Latamoxef sodium |
≥98% | | 询价 |
| 5 | 2648641-36-3 | TPX-0131 |
≥98% | | 询价 |
| 6 | 2201056-66-6 | AG-270 |
≥98% | | 询价 |
| 7 | 915410-98-9 | LP-261 analog |
≥98% | | 询价 |
| 8 | 76985-08-5 | SC10914 |
≥98% | | 询价 |
| 9 | 918639-08-4 | Bosutinib hydrate |
≥98% | | 询价 |
| 10 | 2519823-34-6 | BSJ-4-116 |
≥98% | | 询价 |
| 11 | 2454246-18-3 | YQ128 |
≥98% | | 询价 |
| 12 | 2565705-02-2 | Dot1L-IN-4 |
≥98% | | 询价 |
| 13 | 2070009-66-2 | A-674563 hydrochloride |
≥98% | | 询价 |
| 14 | | pentixather |
≥98% | | 询价 |
| 15 | 2360851-29-0 | RBN012759 |
≥98% | | 询价 |
| 16 | 2243736-37-8 | FTO inhibitor 1 |
≥98% | | 询价 |
| 17 | 2270879-17-7 | BRM/BRG1 ATP Inhibitor-1 |
≥98% | | 询价 |
| 18 | 1295541-87-5 | SCD1 inhibitor-4 |
≥98% | | 询价 |
| 19 | 1638970-43-0 | XQN70430 |
≥98% | | 询价 |
| 20 | 2130996-00-6 | GLPG2938 |
≥98% | | 询价 |
| 21 | 874450-44-9 | SEN-12333 |
≥98% | | 询价 |
| 22 | 1623416-31-8 | AG-636 |
≥98% | | 询价 |
| 23 | 2589531-76-8 | AZD5305 |
≥98% | | 询价 |
| 24 | 2101739-18-6 | RAD51-IN-1 |
≥98% | | 询价 |
| 25 | 129425-81-6 | MSA-2 |
≥98% | | 询价 |
| 26 | 960531-53-7 | Tripeptide-10 Citrulline |
≥98% | | 询价 |
| 27 | 1628252-62-9 | PalMitoyl Tripeptide-1 |
≥98% | | 询价 |
| 28 | 623172-56-5 | Palmitoyl Tripeptide-5 |
≥98% | | 询价 |
| 29 | 2170137-61-6 | GSK3685032(GSK-3685032) |
≥98% | | 询价 |
| 30 | 1535187-91-7 | MC3343 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 31 | 2374152-69-7 | KRAS inhibitor-4 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 32 | 94153-53-4 | Fluoroestradiol F-18(Cerianna) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 33 | 1522051-90-6 | Flortaucipir F18 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 34 | 2055732-84-6 | Viltolarsen(NS-065/NCNP-01) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 35 | 1834610-13-7 | Lumasiran(ALN-G01) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 36 | 2012558-47-1 | Bulevirtide(Myrcludex B MyrB) |
≥98% | | 询价 |
| 37 | 3703-76-2 | Cloperastine |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 38 | 14984-68-0 | Cloperastine HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 39 | 1028332-91-3 | Retreversine |
≥98% | | 询价 |
| 40 | 1202055-39-7 | MPS1/TTK Inhibitor |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 41 | 2597186-19-9 | SR-0813 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 42 | 59588-86-2 | Alamethicin I |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 43 | 7143-21-7 | β-Naphthol violet |
≥98% | | 询价 |
| 44 | 406208-42-2 | ACHP |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 45 | 102146-07-6 | DPCPX |
≥98% | | 询价 |
| 46 | 2416873-83-9 | KB-0742 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 47 | 332382-54-4 | ML-SA1 |
≥98% | | 询价 |
| 48 | 294890-34-9 | 2-({4-[(diphenylacetyl)amino]benzoyl}amino)benzoic acid(5232985) |
| 5mg | 询价 |
| 49 | 43093-97-6 | 2-hydroxy-1-naphthaldehyde 1,3-benzothiazol-2-ylhydrazone(5232755) |
| 5mg | 询价 |
| 50 | 413606-90-3 | 2-[(3-cyano-5-ethyl-4,6-dimethyl-2-pyridinyl)thio]acetamide(5231609) |
| 5mg | 询价 |
| 51 | | 6-[(2-amino-2-oxoethyl)thio]-5-cyano-4-(2-furyl)-2-methyl-N-phenyl-1,4-dihydro-3-pyridinecarboxamide(5231468) |
| 5mg | 询价 |
| 52 | | 1-[(2,4-diphenyl-4H-chromen-3-yl)methyl]piperidine(5231365) |
| 5mg | 询价 |
| 53 | | 4-(1,3-dimethyl-2,3-dihydro-1H-benzimidazol-2-yl)-N,N-dimethylaniline(5231201) |
| 5mg | 询价 |
| 54 | | 4-chloro-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzenesulfonamide(5230110) |
| 5mg | 询价 |
| 55 | | N-cyclohexyl-4-(4-nitrophenoxy)benzenesulfonamide(5229982) |
| 5mg | 询价 |
| 56 | | 5-bromonicotinic acid-2-ethyl-3-methyl-4-quinolinamine(1:1)(5229968) |
| 5mg | 询价 |
| 57 | | 5-(2,3-dihydro-1,4-benzodioxin-2-yl)-4H-1,2,4-triazole-3-thiol(5228930) |
| 5mg | 询价 |
| 58 | | N-(3,5-dibromo-4-hydroxyphenyl)-4-methylbenzenesulfonamide(5228270) |
| 5mg | 询价 |
| 59 | 4946-81-0 | 1-[(3-methoxypropyl)amino]anthra-9,10-quinone(5228195) |
| 5mg | 询价 |
| 60 | | N-(2-hydroxyphenyl)-3-nitrobenzenesulfonamide(5227931) |
| 5mg | 询价 |
m.cnreagent.com